Thalidomide for severe systemic onset juvenile rheumatoid arthritis: A multicenter study. Academic Article uri icon

Overview

abstract

  • Thirteen children with difficult systemic onset juvenile rheumatoid arthritis were treated with thalidomide. At 6 months, 11 of the 13 were able to reduce their use of prednisone ( P < .002), with a concurrent improvement in erythrocyte sedimentation rate ( P < .0001) and an increase in hemoglobin level ( P < 0.005). Juvenile rheumatoid arthritis improvement scores >/=50% were obtained by 10 of the 13 children.

publication date

  • December 1, 2004

Research

keywords

  • Arthritis, Juvenile
  • Immunosuppressive Agents
  • Thalidomide

Identity

Scopus Document Identifier

  • 9744227982

Digital Object Identifier (DOI)

  • 10.1016/j.jpeds.2004.08.020

PubMed ID

  • 15580219

Additional Document Info

volume

  • 145

issue

  • 6